We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
135 hedge funds and large institutions have $1.89B invested in Lexicon Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 41 increasing their positions, 47 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
634% more call options, than puts
Call options by funds: $16.4M | Put options by funds: $2.23M
15% more capital invested
Capital invested by funds: $1.64B → $1.89B (+$252M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.3% less ownership
Funds ownership: 109.45% → 109.14% (-0.3%)
1% less funds holding
Funds holding: 136 → 135 (-1)
4% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 23
13% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 47
Holders
135
Holders Change
-1
Holders Change %
-0.74%
% of All Funds
3.37%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
22
Increased
41
Reduced
47
Closed
23
Calls
$16.4M
Puts
$2.23M
Net Calls
+$14.2M
Net Calls Change
+$13.7M
Top Buyers
| 1 |
UIM
USS Investment Management
London,
United Kingdom
|
+$54.3M |
| 2 |
PA
Pinnacle Associates
New York
|
+$11.1M |
| 3 |
Millennium Management
New York
|
+$7.87M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.58M |
| 5 |
State Street
Boston,
Massachusetts
|
+$5.05M |
Top Sellers
| 1 |
KCM
Kingdon Capital Management
New York
|
-$16.8M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$10.5M |
| 3 |
HCM
Highbridge Capital Management
New York
|
-$7.81M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$7.38M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.12M |
